Eur Rev Med Pharmacol Sci 1999; 3 (2): 53-61

Adrenomedullin assay and its clinical significance

C. Parlapiano, V. Paoletti*, E. Campana, G. Labbadia*, T. Giovanniello, F. Califano, P. Pantone, G. Clemente, L. Donnarumma*, A. Musca*

Istituto II Clinica Medica, Policlinico Umberto I, “La Sapienza”University – Rome (Italy)
*Dipartimento di Terapia Medica, “La Sapienza”University – Rome (Italy)

Abstract. – Adrenomedullin (Am) is a recently discovered peptide, first purified from pheochromocytoma specimens, with a chemical structure similar to that of CGRP and amylin. Adrenomedullin is present in numerous human body tissues and its powerful vasodilatatory activity is thought to play an essential role in cardiovascular and renal homeostasis.

To cite this article

C. Parlapiano, V. Paoletti*, E. Campana, G. Labbadia*, T. Giovanniello, F. Califano, P. Pantone, G. Clemente, L. Donnarumma*, A. Musca*
Adrenomedullin assay and its clinical significance

Eur Rev Med Pharmacol Sci
Year: 1999
Vol. 3 - N. 2
Pages: 53-61

Keywords Related articles:

  1. CGRP and ET-1 plasma levels in normal subjects
  2. Physiological endocrine control of energy homeostasis and postprandial blood glucose levels
  3. CD8+/CD38+: immune activity and clinical significance in HCV patients with and without interferon therapy
  4. Feedback inhibition of insulin secretion and insulin resistance in polycystic ovarian syndrome with and without obesity
  5. Characterisation of the antioxidant effects of Aesculus hippocastanum L. bark extract on the basis of radical scavenging activity, the chemiluminescence of human neutrophil bursts and lipoperoxidation assay